| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $36.8B | $33.4B | $28.2B | $26.3B | $26.0B | $25.4B | $23.4B | $23.7B |
| Cost of Revenue | $12.0B | $12.9B | $8.5B | $6.4B | $6.5B | $6.2B | $4.4B | $4.1B |
| Gross Profit | — | — | — | — | — | $4.7B | $4.6B | $4.9B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $7.0B | $7.1B | $6.2B | $5.4B | $5.4B | $5.7B | $5.2B | $5.3B |
| Operating Income | $9.1B | $7.3B | $7.9B | $9.6B | $7.6B | $9.1B | $9.7B | $10.3B |
| Net Income | $7.7B | $4.1B | $6.7B | $6.6B | $5.9B | $1.6B | $1.7B | $1.9B |
| EPS (Basic) | $14.33 | $7.62 | $12.56 | $12.18 | $10.34 | $2.78 | $2.87 | $3.04 |
| EPS (Diluted) | $14.23 | $7.56 | $12.49 | $12.11 | $10.28 | $2.76 | $2.85 | $3.01 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $90.6B | $91.8B | $97.2B | $65.1B | $61.2B | $62.9B | $59.7B | $66.4B |
| Current Assets | $29.1B | $29.0B | $30.3B | $22.2B | $19.4B | $21.1B | $18.4B | $37.6B |
| Cash & Equivalents | $9.1B | $12.0B | $10.9B | $7.6B | $8.0B | $6.3B | $6.0B | $6.9B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $25.5B | $23.1B | $18.4B | $15.7B | $12.2B | $11.7B | $12.8B | $13.5B |
| Stockholders' Equity | $8.7B | $5.9B | $6.2B | $3.7B | $6.7B | $9.4B | $9.7B | $12.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $10.0B | $11.5B | $8.5B | $9.7B | $9.3B | $10.5B | $9.2B | $11.3B |
| Investing Cash Flow | $-1.9B | $-1.0B | $-26.2B | $-6.0B | $0.7B | $-5.4B | $5.7B | $14.3B |
| Capital Expenditures | $1.9B | $1.1B | $1.1B | $0.9B | $0.9B | $0.6B | $0.6B | $0.7B |
| Financing Cash Flow | $-10.9B | $-9.4B | $21.0B | $-4.0B | $-8.3B | $-4.9B | $-15.8B | $-22.5B |